Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Irene A Abela, Alexandra U Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Matthieu Perreau, Hans H Hirsch, Hansjakob Furrer, Alexandra Calmy, Patrick Schmid, Matthias Cavassini, Enos Bernasconi, Huldrych F Günthard & Swiss HIV Cohort Study
Although ADR has become very rare with cART due to new potent therapies, patients in socially challenging life situations or presenting with mental health issues are at higher risk for drug resistance. Prompt identification and adequate support of these patients before ADR will prevent treatment failure and HIV-1 transmission.
|citation||Abela I A, Scherrer A U, Böni J, Yerly S, Klimkait T, Perreau M, Hirsch H H, Furrer H, Calmy A, Schmid P, Cavassini M, Bernasconi E, Günthard H F, Swiss HIV Cohort Study . Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. Clin Infect Dis 2020; 70:297-303.|
|type||journal paper/review (English)|
|date of publishing||02-1-2020|
|journal title||Clin Infect Dis (70/2)|